Author:
Hohenberger P.,Hohenberger W.
Publisher
Springer Berlin Heidelberg
Reference33 articles.
1. Bonvalot S, Lejeune F, Laplanche A et al (2003) Limb salvage by isolated limb perfusion (ILP) in patients with locally advanced soft tissue sarcoma (ASTS): A randomized phase II study comparing 4 doses of TNFα. Proc Am Coc Clin Oncol 22:823 (abstr3307)
2. Eggermont AM, Schraffordt-Koops H, Klausner JM et al (1996) Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. Ann Surg 224: 756–764
3. Eggermont AM, Schraffordt Koops H, Liénard D et al (1996) Isolated limb perfusion with high-dose tumor necrosis factor-α in combination with interferon-γ and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. J Clin Oncol. 14:2653–2665
4. Fraker DL, Alexander HR, Andrich M, Rosenberg SA (1996) Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon c: results of a tumor necrosis factor dose-escalation study. J Clin Oncol 14:479–489
5. Fraker DL, Alexander HR, Ross M et al (2002) A phase III trial of isolated limb perfusion for extremity melanoma comparing melphalan alone versus melphalan plus TNF plus interferon-gamma Ann Surg Oncol 9 (Suppl):A1